Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000176 · ClinicalTrials.gov registry record · Phase 3

Alzheimer's Disease Prevention Trial

A Phase 3 study, sponsored by National Institute on Aging (NIA).

Completed
Registry status
Phase 3
Development phase

NCT00000176 is a Phase 3 study that has completed, run by National Institute on Aging (NIA).

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000176, a Phase 3 study, has completed, sponsored by National Institute on Aging (NIA).

COMPLETED
Registry status
Phase 3
Development phase

Study Summary

This is a three-year study to determine if estrogens can prevent memory loss and Alzheimer's disease in women with a family history of Alzheimer's disease.

Interventions

  • DRUG Estrogen
  • DRUG Estrogen and Progesterone

Trial Details

FieldValue
Est. Completion 2007-09
Phase Phase 3

Sponsor

National Institute on Aging (NIA)

131 total trials

What the Registry Record Tells You About NCT00000176

The ClinicalTrials.gov registry entry for NCT00000176 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Estrogen is the first listed.

NCT00000176 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00000176 about?

NCT00000176 is a clinical study titled "Alzheimer's Disease Prevention Trial". This is a three-year study to determine if estrogens can prevent memory loss and Alzheimer's disease in women with a family history of Alzheimer's disease.

What is the current status of trial NCT00000176?

This trial is currently completed. It is a Phase 3 study. Estimated completion is 2007-09.

What interventions are being tested in trial NCT00000176?

The interventions under investigation include: Estrogen (DRUG), Estrogen and Progesterone (DRUG).

Who is sponsoring clinical trial NCT00000176?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.